Business Description
Zepp Health Corp
ISIN : US98945L2043
Share Class Description:
ZEPP: ADRTotal Employee Number:
763Compare
Compare
Traded in other countries / regions
ZEPP.USAST0.GermanyZEPP N.Mexico Index Membership
NASDAQ Golden Dragon China Index IPO Date
2018-02-08Description
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands. Geographically, the group generates revenue from Asia-Pacific, Europe, North America and others.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.22 | |||||
Equity-to-Asset | 0.37 | |||||
Debt-to-Equity | 1.23 | |||||
Debt-to-EBITDA | -8.2 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 0.31 | |||||
Beneish M-Score | -2.4 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -25.8 | |||||
3-Year EBITDA Growth Rate | 14.3 | |||||
3-Year EPS without NRI Growth Rate | 5.1 | |||||
3-Year FCF Growth Rate | 40 | |||||
3-Year Book Growth Rate | -16.7 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 59.98 | |||||
9-Day RSI | 50.82 | |||||
14-Day RSI | 42.81 | |||||
3-1 Month Momentum % | -69.45 | |||||
6-1 Month Momentum % | -84.92 | |||||
12-1 Month Momentum % | -34.48 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.88 | |||||
Quick Ratio | 0.67 | |||||
Cash Ratio | 0.18 | |||||
Days Inventory | 159.95 | |||||
Days Sales Outstanding | 88.52 | |||||
Days Payable | 170.84 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 1.4 | |||||
Shareholder Yield % | -38.46 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 38.35 | |||||
Operating Margin % | -10.5 | |||||
Net Margin % | -14.7 | |||||
EBITDA Margin % | -10.73 | |||||
FCF Margin % | -9.74 | |||||
OCF Margin % | -9.45 | |||||
ROE % | -18.29 | |||||
ROA % | -7.26 | |||||
ROIC % | -6.72 | |||||
3-Year ROIIC % | -21.36 | |||||
ROC (Joel Greenblatt) % | -30.24 | |||||
ROCE % | -10.25 | |||||
Years of Profitability over Past 10-Year | 6 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 3 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shiller PE Ratio | 534 | |||||
PS Ratio | 0.28 | |||||
PB Ratio | 0.4 | |||||
Price-to-Tangible-Book | 0.46 | |||||
EV-to-EBIT | -9.09 | |||||
EV-to-Forward-EBIT | 3.37 | |||||
EV-to-EBITDA | -9.09 | |||||
EV-to-Forward-EBITDA | 3.13 | |||||
EV-to-Revenue | 0.98 | |||||
EV-to-Forward-Revenue | 0.19 | |||||
EV-to-FCF | -10.02 | |||||
Price-to-GF-Value | 1.3 | |||||
Price-to-Projected-FCF | 3.66 | |||||
Earnings Yield (Greenblatt) % | -11 | |||||
FCF Yield % | -33.81 | |||||
Forward Rate of Return (Yacktman) % | 51.82 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:ZEPP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zepp Health Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 271.907 | ||
| EPS (TTM) ($) | -4 | ||
| Beta | 2.9712 | ||
| 3-Year Sharpe Ratio | 0.54 | ||
| 3-Year Sortino Ratio | 2.52 | ||
| Volatility % | 478.52 | ||
| 14-Day RSI | 42.81 | ||
| 14-Day ATR ($) | 0.643716 | ||
| 20-Day SMA ($) | 4.954 | ||
| 12-1 Month Momentum % | -34.48 | ||
| 52-Week Range ($) | 3.85 - 61.85 | ||
| Shares Outstanding (Mil) | 14.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zepp Health Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zepp Health Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-04 08:30 | In 117 days | ||
| Third quarter earnings results for 2026 | 2026-11-04 | In 116 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-03 21:30 | In 25 days | ||
| Second quarter earnings results for 2026 | 2026-08-03 | In 23 days | ||
| First quarter earnings conference call for 2026 | 2026-06-08 21:30 | 6.19 (-4.77%) | ||
| First quarter earnings results for 2026 | 2026-06-08 | 6.19 (-4.77%) | ||
| Annual report for 2025 | 2026-04-24 | 16.52 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-15 21:30 | 20.83 (-1.42%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-15 | 20.83 (-1.42%) | ||
| Third quarter earnings conference call for 2025 | 2025-11-04 08:30 | 38.90 (-4.42%) |
Show
Entries
Zepp Health Corp Frequently Asked Questions
What is Zepp Health Corp(ZEPP)'s stock price today?
The current price of ZEPP is $5.34. The 52 week high of ZEPP is $61.85 and 52 week low is $3.85.
When is next earnings date of Zepp Health Corp(ZEPP)?
The next earnings date of Zepp Health Corp(ZEPP) is 2026-08-03 Est..
Does Zepp Health Corp(ZEPP) pay dividends? If so, how much?
Zepp Health Corp(ZEPP) does not pay dividend.
Guru Commentaries on NYSE:ZEPP
No articles.
Press Release
Articles on Zepp Health Corp
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers